ANIP

ANI Pharmaceuticals, Inc.

Healthcare›Drug Manufacturers - Specialty & Generic|NASDAQ Global Market|US

Price

$74.21

Market Cap

$1.67B

Beta

0.43

P/E

24.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+43.78%

EPS Growth (YoY)+396.46%

Revenue CAGR 3Y+40.81%

P/E Ratio24.0

PEG Ratio0.06

FCF Yield+7.71%

Debt / Equity0.60

Interest Coverage2.5x

No credit card required

Already have an account? Sign in to view the full analysis for ANIP.